Syncom Formulations (India) Limited
SYNCOMF

Syncom Formulations (India) Limited

Pharmaceuticals
Share price
16
Market cap
₹1,517 Cr
1Y return
7%

A global generic pharmaceutical company established in 1995, Syncom Formulations manufactures and markets a comprehensive range of healthcare products across multiple therapeutic areas. Operating in more than 15 countries worldwide with registrations for over 400 pharmaceutical products, the company serves both domestic and international markets. Its distinctive strength lies in its diversified geographic footprint and expansive product portfolio catering to varied patient healthcare needs globally.

Track the whales in Syncom Formulations (India) Limited

Get alerted the moment a top investor buys or sells.

Get started
Syncom Formulations (India) — investor holdings · WhaleWatch